IPO: GreenSignal Bio Pharma Limited
Company & Business Profile
GSBPL operates in a very niche and highly potential space of vaccines in the Pharma Industry. The opportunity is global and the market place has very limited suppliers. GSBPL is all set to make a giant leap into the big league of vaccine manufacturing. There are only four companies in the world, pre-qualified by WHO for supply of BCG Vaccine for immunization against Tuberculosis to UNICEF. GSBPL is one of them and one of the two suppliers of BCG Vaccine in India. Vaccines manufactured by the Green Signal Bio Pharma Limited are accredited by the World Health Organization, Geneva and are being used in countries across the globe in their national immunization programs, saving millions of lives throughout the world.
Objects of the Issue
- To achieve the benefits of listing the equity Shares on the BSE and the NSE.
- To carry out the sale of up to 14,579,560 equity shares by the selling shareholders.
- To enhance visibility and brand image among existing and potential customers.
- To provide liquidity to the existing shareholders.
Listing
The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).
Apply in IPO now in ASBA mode, to apply call us at 0731-4217261. Read http://bit.ly/2fyxpSn to know further
